Derivation of a melamine oral reference dose (RfD) and drinking-water total allowable concentration

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 13, Issue 1, 2010, Pages 16-50

  Bhat, Virunya S ^a   Ball, Gwen L ^a   McLellan, Clifton J ^a  

^a NSF INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; MELAMINE; URIC ACID; TRIAZINE DERIVATIVE;

ACUTE KIDNEY FAILURE; ARTICLE; ARTIFICIAL MILK; BLADDER; BLADDER CARCINOMA; BLADDER EPITHELIUM; BLADDER PAPILLOMA; CAT; DEATH; DOG; EPITHELIUM HYPERPLASIA; FEMALE; GENOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERSTITIAL CYSTITIS; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PREMATURITY; RAT; UROLITHIASIS; ADULT; ANIMAL; CHEMICALLY INDUCED DISORDER; CHILD; DOSE RESPONSE; DRUG SURVEILLANCE PROGRAM; ENVIRONMENTAL EXPOSURE; FISCHER 344 RAT; MUTAGEN TESTING; PREGNANCY; REFERENCE VALUE; STANDARD; URINARY TRACT CANCER; WATER SUPPLY; WISTAR RAT;

MUS; RATTUS;

ADULT; ANIMALS; CATS; CHILD; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MICE; MUTAGENICITY TESTS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PREGNANCY; RATS; RATS, INBRED F344; RATS, WISTAR; REFERENCE VALUES; TRIAZINES; UROLITHIASIS; UROLOGIC NEOPLASMS; WATER SUPPLY;

EID: 77950472869     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937401003673784     Document Type: Article

References (137)

1. Aalto-Korte, K., Jolanki, R., and Estlander, T. 2003. Formaldehyde-negative allergic contact dermatitis from melamine-formaldehyde resin. Contact Dermatitis 49:194-196. (Pubitemid 38230765)
2. American Cyanamid Company. 1955. Melamine: Acute and chronic toxicity. Report 55-21, unpublished data, 1955. Based on OECD (1998). Wayne, NJ: American Cyanamid Company.
3. American Cyanamid Company. 1981a. in Vitro Sister Chromatid Exchange in Chinese Hamster Ovary Cells (CHO). Wayne, NJ: American Cyanamid Company.
4. American Cyanamid Company. 1981b. Genetic toxicology micronucleus test (MNT). Wayne, NJ: American Cyanamid Company.
5. American Cyanamid Company. 1981c. Determination of the mutagenic potential of melamine using the CHO/HGPRT Chinese hamster ovary cell forward mutation assay. Wayne, NJ: American Cyanamid Company.
6. American Cyanamid Company. 1982. Rat hepatocyte primary culture/DNA repair test. Wayne, NJ: American Cyanamid Company.
7. Ames, M. M. 1991. Hexamethylmelamine: Pharmacology and mechanism of action. Cancer Treat. Rev. 18(suppl. A):3-14.
8. BASF AG. 1969. Department of Toxicology, unpublished data (XIX/5), 23.04. Cited in OECD (1998).
9. Baynes, R. E., Smith, G., Mason, S. E., Barrett, E., Barlow, B. M., and Riviere, J. E. 2008. Pharmacokinetics of melamine in pigs following intravenous administration. Food Chem Toxicol. 46:1196-2000.
10. Blair, A., Stewart, P., and Hoover, R. 1990. Mortality from lung cancer among workers employed in formaldehyde industries. Am. J. Ind. Med. 17:683-699. (Pubitemid 20229857)
11. Brown, C. A., Jeong, K. S., Poppenga, R. H., Puschner, B., Miller, D. M., Ellis, A. E., Kang, K. I., Sum, S., Cistola, A. M., and Brown, S. A. 2007. Outbreaks of renal failure associated with melamine and cyanuric acid in dogs and cats in 2004 and 2007. J. Vet. Diagn. Invest. 19:525-531. (Pubitemid 351202195)
12. Burns, K. 2007a. Events leading to the major recall of pet foods. J. Am. Vet. Med. Assoc. 230:1600-1604.
13. Burns, K. 2007b. Researchers examine contaminants in food, deaths of pets. J. Am. Vet. Med. Assoc. 231:1636-1638. (Pubitemid 350305121)
14. Buur, J. L., Baynes, R. E., and Riviere, J. E. 2008. Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model. Regul. Toxicol. Pharmacol. 51:324-331.
15. Burin, G. J., Gibb, H. J., and Hill, R. N. 1995. Human bladder cancer: evidence for a potential irritation-induced mechanism. Food Chem. Toxicol. 33:785-795.
16. Burrows, E., Brueggeman, E., and Hoke, S. 1984. Chromatographic trace analysis of guanidine, substituted guanidines and striazines in water. J. Chromatogr. 294: 494-498. (Pubitemid 14085755)
17. Campbell, T. W. 2004. Clinical chemistry of mammals, laboratory animals and nondomestic species. In Veterinary hematology and clinical chemistry, eds. M. A. Thrall, D. C. Baker, T. W. Campbell, D. B. DeNicola, M. J. Fettman, E. D. Lassen, A. Rebar, and G. Weiser, pp. 463-478. Ames, IA: Blackwell.
18. Chan, E. Y., Griffiths, S. M., and Chan, C. W. 2008. Public-health risks of melamine in milk products. Lancet 372:1444-1445.
19. ChemIDplus. 2009. National Library of Medicine on-line database. Available at: http:// chem.sis.nlm.nih.gov/chemidplus
20. Cheng, L. 1980. Urinary tract calculi in man and laboratory animals: Incidence, composition, and etiology. J. Environ. Pathol. Toxicol. 4:317-349. (Pubitemid 11172097)
21. Chin, T. Y., Tyl, R. W., Popp, J. A., and Heck, H. A. 1981. Chemical urolithiasis 1. Characteristics of bladder stone induction by terephthalic acid and dimethyl terephthalate in weanling Fischer-344 rats. Toxicol. Appl. Pharmacol. 58:307-321.
22. Chiu, M. C. 2008. Melamine-tainted milk product (MTMP) renal stone outbreak in humans. Hong Kong Med J. 14:424-426.
23. Cianciolo, R. E., Bischoff, K., Ebel, J. G., Van Winkle, T. J., Goldstein, R. E., and Serfilippi, L. M. 2008. Clinicopathologic, histologic, and toxicologic findings in 70 cats inadvertently exposed to pet food contaminated with melamine and cyanuric acid. J. Am. Vet. Med. Assoc. 233:729-737.
24. Clark, R. 1966. Melamine crystalluria in sheep. J. South Afr. Vet. Med. Assoc. 37:349-351.
25. Clayson, D. B. 1974. Bladder carcinogenesis in rats and mice: possibility of artifacts. J. Natl. Cancer Inst. 52:1685-1689.
26. Clayson, D. B., Fishbein, L., and Cohen, S. M. 1995. Effects of stones and other physical factors on the induction of rodent bladder cancer. Food Chem. Toxicol. 33: 771-784.
27. Cocchi, M., Vascellari, M., Gallina, A., Angeletti, R., Agnoletti, F., Mutinelli, F., and Cattai, S. 2009. Renal failure in dogs in Italy associated with melamine-contaminated pet food. Vet. Rec. 164:407-408.
28. Cohen, S. M. 1995. Role of urinary physiology and chemistry in bladder carcinogenesis. Food Chem. Toxicol. 33:715-730.
29. Cohen, S. M. 1999. Calcium phosphate-containing urinary precipitate in rat urinary bladder carcinogenesis. IARC Sci. Publ. 147:175-189.
30. Cohen, S. M., Arnold, L. L., Cano, M., Ito, M., Garland, E. M., and Shaw, R. A. 2000. Calcium-phosphate-containing precipitate and the carcinogenicity of sodium salts in rats. Carcinogenesis 21:783-792. (Pubitemid 30214037)
31. DeFoor, W., Minevich, E., Jackson, E., Reddy, P., Clark, C., Sheldon C., and Asplin, J. 2008. Urinary metabolic evaluations in solitary and recurrent stone forming children. J. Urol. 179:2369-2372.
32. DeSesso, J. M. 1995. Anatomical relationships of urinary bladders compared: Their potential role in the development of bladder tumors in humans and rats. Food Chem. Toxicol. 33: 70-714.
33. Dobson, R. L., Motlagh, S., Quijano, M., Cambron, R. T., Baker, T. R., Pullen, A. M., Regg, B. T., Bigalow-Kern, A. S., Vennard, T., Fix, A., Reimschuessel, R., Overmann, G., Shan, Y., and Daston, G. .P. 2008. Identification and characterization of toxicity of contaminants in pet food leading to an outbreak of renal toxicity in cats and dogs. Toxicol Sci. 106: 251-262.
34. European Food Safety Authority. 2008. Statement of EFSA on risks for public health due to the presences of melamine in infant milk and other milk products in China. Question number: EFSA-Q-2008-695. Adopted date: 24 September 2008. Available at: http://www.efsa. europa.eu/EFSA/efsa-locale-1178620753812- 1211902098495.htm. Accessed November 17, 2008
35. Fassett, D. W., and Roudabush, R. L. 1963. Laboratory of Industrial Medicine, Eastman Kodak Company, unpublished observations. Cited in OECD (1998).
36. Filigenzi, M. S., Puschner, B., Aston, L. S., and Poppenga, R. H. 2008. Diagnostic determination of melamine and related compounds in kidney tissue by liquid chromatography/ tandem mass spectrometry. J. Agric. Food Chem. 56:7593-7599.
37. Filigenzi, M. S., Tor, E. R., Poppenga, R. H., Aston, L. A., and Puschner, B. 2007. The determination of melamine in muscle tissue by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass. Spectrom. 21:4027-4032.
38. Foureman, P., Mason, J. .M., Valencia, R., and Zimmering, S. 1994. Chemical mutagenesis testing in Drosophila. X. Results of 70 coded compounds tested for the National Toxicology Program. Environ. Mol. Mutagen. 23:208-227. (Pubitemid 24147776)
39. Galloway, S., Armstrong, M., Reuben, C., Colman, S., Brown, B., and Cannon, C. 1987. Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: Evaluations of 108 chemicals. Environ. Mol. Mutagen. 10(suppl. 10):1-179. (Pubitemid 18039247)
40. García-Gavin, J., Loureiro-Martinez, M., Fernandez-Redondo, V., Seoane, M. J., and Toribio, J. 2008. Contact allergic dermatitis from melamine formaldehyde resins in a patient with a negative patch-test reaction to formaldehyde. Dermatitis 19:E5-E6.
41. García-Nieto, V., Navarro, J. F., Luis-Yanes, M. I., López-Méndez, M., and García-Rodríguez, V. 2007. Hypercalciuria in pediatric patients with ureteropelvic junction obstruction is of genetic origin. Scand. J. Urol. Nephrol. 41:144-148. (Pubitemid 46598102)
42. Gossner, C. M., Schlundt, J., Embarek, P. B., Hird, S., Wong, D. L., Beltran, J. J., Teoh, K. N. and Tritscher, A. 2009. The melamine incident: Implications for international food and feed safety. Environ. Health Perspect. 117:1803-1808.
43. Guan, N., Fan, Q., Ding, J., Zhao, Y., Lu, J., Ai, Y., Xu, G., Zhu, S., Yao, C., Jiang, L., Miao, J., Zhang, H., Zhao, D., Liu, X., and Yao, Y. 2009. Melamine-contaminated powdered formula and urolithiasis in young children. N. Engl. J. Med. 360:1067-1074.
44. Hard, G., Flake, G., and Sills, R. 2009. Reevaluation of kidney histopathology from 13-week toxicity and 2-year carcinogenicity studies of melamine in the F344 rat: Morphological evidence of retrograde nephropathy. Vet Pathol. July 15. Epub ahead of print.
45. Hau, A. K.-C., Kwan, T. H., and Li, P. K.-T. 2009. Melamine toxicity and the kidney. J. Am. Soc. Nephrol. 20:245-250.
46. Hawley, G. G., ed. 1981. The condensed chemical dictionary, 10th ed., p. 649. New York: Van Nostrand Reinhold.
47. Haworth, S., Lawlor, T. Mortelmans, K., Speck, W., and Zeiger, E. 1983. Salmonella mutagenicity test results for 250 chemicals. Environ. Mutagen. Suppl. 1:3-142. (Pubitemid 14168891)
48. Hazardous Substances Database. 2009. Online database. Available at: http://toxnetnlm. nih.gov/cgi-bin/sis/htmlgen?HSDB
49. Health Canada. 2008. The Government of Canada responds to reports of melamine in food products. Available at: http://www.hcsc. gc.ca/fn-an/securit/ chem-chim/melamineeng. php. Accessed November 17, 2008.
50. Heck, H. A., and Tyl, R. 1985. The induction of bladder stones by terephthalic acid, dimethyl terephthalate, and melamine (2,4,6-triamino-s- triazine) and its relevance to risk assessment. Reg. Toxicol. Pharmacol. 5: 295-313. (Pubitemid 16214599)
51. Heil, J., and Reifferscheid, G. 1992. Detection of mammalian carcinogens with an immunological DNA synthesis-inhibition test. Carcinogenesis 13:2389-2394. (Pubitemid 23022986)
52. Hellwig J., Gembrandt, C., and Hildebrandt, B. 1996. Melamine-Prenatal toxicity in Wistar rats after oral administration (diet). Project No. 32R0242/94007. Cited in OECD (1998).
53. Hofstetter, J., Suckow, M. A., and Hickman, D. L. 2006. Morphophysiology. In The laboratory rat, eds. M. A. Suckow, S. H. Weisbroth, and C. L. Franklin, 2nd ed, pp. 93-120. San Diego, CA: Elsevier Academic Press.
54. Homma, Y., and Oyasu, R. 1986. Transient and persistent hyperplasia in heterotopically transplanted rat urinary bladders induced by formalin and foreign bodies. J. Urol. 136:136-140. (Pubitemid 16059619)
55. International Agency for Research on Cancer. 1987. Overall evaluations of carcinogenicity: An updating of IARC Monographs Volumes 1 to 42. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Suppl. 7:65.
56. International Agency for Research on Cancer. 1999. Some chemicals that cause tumours of the kidney or urinary bladder in rodents and some other substances. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 73. Available at: http:// monographs.iarc.fr/ENG/Monographs/vol73/ mono73-17.pdf. Accessed November 19, 2008.
57. Ishiwata, H., Inoue, T., Yamazaki, T., and Yoshihira, K. 1987. Liquid chromatographic determination of melamine in beverages. J. Assoc. Off. Anal. Chem. 70:457-460.
58. Jia, X. D., Li, N., Wang, Z. T., Zhao, Y. F., Wu, Y. N., and Yan, W. X. 2009. Assessment on dietary melamine exposure from tainted infant formula. Biomed. Environ. Sci. 22: 100-103.
59. Jia, L.-Q., Shen, Y., Wang, X.-M., He, L.-J., Xin, Y., and Hu, Y.-X. 2009. Ultrasonographic diagnosis of urinary calculus caused by melamine in children. Chin. Med. J. 122: 252-256.
60. Lahalih, S. M., and Absi-Halabi, M. 1989. Recovery of solids from melamine waste effluents and their conversion to useful products. Ind. Eng. Chem. Res. 28:500-504. (Pubitemid 19108334)
61. Lam, H. S., Ng, P. C., Chu, W. C., Wong, W., Chan, D. F., Ho, S. S., Wong, K. T., Ahuja, A. T., and Li, C. K. 2008. Renal screening in children after exposure to low dose melamine in Hong Kong: Cross sectional study. Br. Med. J. 337:a2991.
62. Lam, C.-W., Lan, L., Che, X., Tam, S., Wong, S. S.-Y., Chen, Y., Jin, J., Tao, S.-H., Tang, X.-M., Yuen, K.-Y., and Tam, P. K.-H. 2009. Diagnosis and spectrum of melaminerelated renal disease: Plausible mechanism of stone formation in humans. Clin. Chim. Acta 402:150-155.
63. Lehman-McKeeman, L. D., and Caudill, C. 1991. Quantitation of a-2μ-globulin and albumin by reverse-phase high performance liquid chromatography. J. Pharmacol. Methods 26:239-247.
64. Li, G., Jiao, S., Yin, X., Deng, Y., Pang, X., and Wang, Y. 2009. The risk of melamine-induced nephrolithiasis in young children starts at a lower intake level than recommended by the WHO. Pediatr. Nephrol. September 1. Epub ahead of print.
65. Lipschitz W. L., and Stokey, E. 1945. The mode of action of three new diuretics: Melamine, adenine and formoguanamine. J. Pharmacol. Exp. Ther. 83:235-249.
66. Litton Bionetics. 1977a. Mutagenicity evaluation of melamine, unpublished data, LBI Project No. 2838, 1977 Based on OECD (1998)
67. Litton Bionetics. 1977b. Unpublished data. Cited in OECD (1998).
68. Lu, J., Xiao, J., Yang, Z. T., Jiang, D. G., Fang, C. R., and Yang, J. 2009. Study on migration of melamine from food packaging material on markets. Biomed. Environ. Sci. 22:104-108.
69. Lund, K. H., and Petersen, J. H. 2006. Migration of formaldehyde and melamine monomers from kitchen- and tableware made of melamine plastic. Food Addit. Contam. 23: 948-955.
70. MacKenzie, H. I. 1966. Melamine for sheep. J. South Africa Vet. Med. Assoc. 37:153-157.
71. Mandeville, J. A., and Nelson, C. P. 2009. Pediatric urolithiasis. Curr. Opin. Urol. 19:419-423.
72. Marsh, G., Stone, R., and Henderson, V. 1992. Lung cancer mortality among industrial workers exposed to formaldehyde: A Poisson regression analysis of the National Cancer Institute Study. Am. Ind. Hyg. Assoc. J. 53:681-691.
73. Martin, R. E., Hizo, C. B., Ong, A. M., Alba, O. M., and Ishiwata, H. 1992. Release of formaldehyde and melamine from melamine tableware manufactured in the Philippines. J. Food Prot. 55:632-635. (Pubitemid 20072307)
74. Mast, R., Naismith, R., and Friedman, M. 1982. Mouse micronucleus assay of melamine. Environ. Mutagen. 4:340 (abstr.).
75. Mast, R. W., Jeffcoat, A. R., and Sadler, B. M. 1983. Metabolism disposition and excretion of [14C]melamine in male Fischer 344 rats. Food Chem. Toxicol. 21:807-810. (Pubitemid 14216195)
76. McGregor, D., Brown, A., Cattanach, P., Edwards, I., McBride, D., Riach, C., and Caspary., W. 1988. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. III. 72 coded chemicals. Environ. Mol. Mutagen. 12:85-154. (Pubitemid 18056303)
77. Meek, M. E., Bucher, J. R., Cohen, S. M., Dellarco, V., Hill, R. N., Lehman-McKeeman, L. D., Longfellow, D. G., Pastoor, T., Seed, J., and Patton, D. E. 2003. A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev.Toxicol. 33:591-653. (Pubitemid 38040084)
78. Melnick, R. L., Boorman, G. A., Haseman, J. K., Montali, R. J., and Huff, J. 1984. Urolithiasis and bladder carcinogenicity of melamine in rodents. Toxicol. Appl. Pharmacol. 72:292-303.
79. Ministry of Health of the People's Republic of China. 2008. Preliminary fact sheet concerning urinary stone relating to melamine-tainted milk formula in children. September 12, 2008. Available at: http://www.moh. gov.cn/ publicfiles/business/htmlfiles/mohbgt/s3582/ 200809/37783.htm. Accessed April 9, 2009.
80. National Toxicology Program. 1981. Melamine. In vitro Information. Salmonella. Available at: http://ntp-apps.niehs.nih.gov/ ntp-tox/index.cfm? fuseaction=ntpsearch. searchresults&searchterm=108%2D78%2D1 &crumbspot=1. Accessed March 3, 2008.
81. National Toxicology Program. 1983. Carcinogenesis bioassay of melamine (CAS no. 108-78-1) in F344/N rats B6C3F1 mice (Feed study). Springfield, VA: U.S. Department of Commerce, National Technical Information Service. PB83-202630.
82. National Toxicology Program. 1988. Melamine. In Vivo information. Rodent bone marrow cytogenetics-Sister chromatid exchanges. Study number 951364. Available at: Accessed March 3, 2008. http://ntp-apps.niehs.nih.gov/ntp-tox/ index.cfm?fuseaction=ntpsearch.searchresults&searchterm=108%2D78%2D1& crumbspot=1
83. National Toxicology Program. 1989a. Melamine. In vivo information. Rodent bone marrow cytogenetics-Chromosomal aberrations. Study number 951364. Available at: http://ntp-apps.niehs.nih.gov/ntp-tox/index. cfm?fuseaction= ntpsearch.searchresults& searchterm=108%2D78%2D1&crumbspot =1. Accessed March 3, 2008.
84. National Toxicology Program. 1989b. Melamine. In vivo information. Micronucleus, peripheral blood, bone marrow. Available at: http://ntpapps. niehs.nih.gov/ntp-tox/index.cfm?fuseaction= ntpsearch. searchresults&searchterm= 108%2D78%2D1&crumbspot=1. Accessed March 3, 2008.
85. National Toxicology Program. 2008. NTP research concept: Melamine/cyanuric acid. Presented by G. Gamboa da Costa, National Center for Toxicological Research, U.S. FDA, at NTP Board of Scientific Counselors Meeting, June 11-12. Available at: http:// ntp.niehs.nih.gov/index.cfm?objectid= 78A617B9-F1F6-975E-7F3871DF6BC95C22. Accessed July 18, 2008.
86. NSF/ANSI 61. 2008. NSF international standard/ American national standard for drinking water additives. drinking water system components-Health effects. Ann Arbor, MI: NSF International.
87. Ogaswara, H., Imaida, K., Ishiwata, H., Toyoda, K., Kawanishi, T., Uneyama, C., Hayashi, S., Takahashi, M., and Hayashi, Y. 1995. Urinary bladder carcinogenesis induced by melamine in F344 male rats: Correlation between carcinogenicity and urolith formation. Carcinogenesis 16:2773-2777.
88. Okumura, M., Hasegawa, R., Shirai, T., Ito, M., Yamada, S., and Fukushima, S. 1992. Relationship between calculus formation and carcinogenesis in the urinary bladder of rats administered the non-genotoxic agents, thymine or melamine. Carcinogenesis 13:1043-1045.
89. Organization for Economic Cooperation and Development. 1998. Melamine. Screening information dataset (SIDS). June. Available at: http://www.chem.unep. ch/irptc/sids/ OECDSIDS/108781.pdf. Accessed December 11, 2007.
90. Organization for Economic Cooperation and Development. 2004. The 2004 OECD list of high production volume chemicals. Paris: OECD. Available at: http://cs3-hq.oecd.org/ scripts/hpv/.
91. Osborne, C. A., Lulich, J. P., Ulrich, L. K., Koehler, L. A., Albasan, H., Sauer, L., and Schubert, G. 2009. Melamine and cyanuric acid-induced crystalluria, uroliths, and nephrotoxicity in dogs and cats. Vet. Clin. North Am. Small Animal Pract. 39:1-14.
92. Oyasu, R., Iwasaki, T., and Ozono, S. 1984. Diffuse papillomatosis of rat urinary bladder occurring in association with vesical calculi. J. Urol. 132:1012-1015. (Pubitemid 14023531)
93. Parry, J. 2008. Contaminated infant formula sickens 6200 babies in China. Br. Med. J. 337:1738.
94. Perrella, F. W., and Boutwell, R. K. 1983. Triethylenemelamine: An initiator of two-stage carcinogenesis in mouse skin which lacks the potential of a complete carcinogen. Cancer Lett. 21:37-41.
95. Porowski, T., Zoch-Zwierz, W., Konstantynowicz, J., and Taranta-Janusz, K. 2008. A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index. Pediatr. Nephrol. 23:1123-1128.
96. Pukkila, J., Peltonen, K., and Savolainen, T. 1987. Determination of melamine in air by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 411:409-414.
97. Puschner, B., Poppenga, R. H., Lowenstein, L. J., Filigenzi, M. S., and Pesavento, P. A. 2007. Assessment of melamine and cyanuric acid toxicity in cats. J. Vet. Diagn. Invest. 19: 616-624. (Pubitemid 351202170)
98. Reimschuessel, R., Gieseker, C. M., Miller, R. A., Ward, J., Boehmer, J., Rummel, N., Heller, D. N., Nochetto, C., de Alwis, G. K., Bataller, N., Andersen, W.C., Turnipseed, S.B., Karbiwnyk, C. M., Satzger, R. D., Crowe, J. B., Wilber, N. R., Reinhard, M. K., Roberts, J. F., and Witkowski, M. R. 2008. Evaluation of the renal effects of experimental feeding of melamine and cyanuric acid to fish and pigs. Am. J. Vet. Res. 69:1217-1228.
99. Rijcken W. R. P. 1995. Primary skin irritation/ corrosion study with melamine in the rabbit, confidential unpublished Notox project 146205 for DSM Melamine. Cited by OECD (1998).
100. Ripperger, W., and Frankenthal, D. E. 2005. Process for the production of high purity melamine from urea. U.S. Patent 6858730. Available at: http://www.freepatentsonline. com/6858730.html. Accessed December 5, 2008.
101. Rossman, T., Molina, M., Meyer, L., Boone, P., Klein, C., Wang, Z., Li, F., Lin, W., and Kinney, P. 1991. Performance of 133 compounds in the lambda prophage induction endpoint of the microscreen assay and a comparison with S. typhimurium mutagenicity and rodent carcinogenicity assays. Mutat. Res. 260:349-367.
102. Sampath, A., Kossoff, E. H., Furth, S. L., Pyzik P. L., and Vining, E. P. 2007. Kidney stones and the ketogenic diet: Risk factors and prevention. J. Child. Neurol. 22:375-378. (Pubitemid 46915269)
103. Seiler, J. P. 1973. A survey on the mutagenicity of various pesticides. Experientia 29: 622-623.
104. Selden J., Dolbeare, F., Clair, J., Miller, J., McGettigan, K., DiJohn, J., Dysart, G., and DeLuca, J. 1994. Validation of a flow cytometric in vitro DNA repair (UDS) assay in rat hepatocytes. Mutat. Res. 315: 147-167. (Pubitemid 24267381)
105. Shelby, M. D., Erexson, G. L., Hook, G. J., and Tice, R. R. 1993. Evaluation of a threeexposure mouse bone marrow micronucleus protocol: Results with 49 chemicals. Environ. Mol. Mutagen. 21:160-179.
106. 2]Oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria. Kidney Int. 73:1181-1186. (Pubitemid 351620437)
107. Spivacow, F. R., Negri, A. L., del Valle, E. E., Calviño, I., Fradinger, E., and Zanchetta, J. R. 2008. Metabolic risk factors in children with kidney stone disease. Pediatr. Nephrol. 23:1129-1133.
108. Srivastave, A., Gupta, B., Gaur, J., and Bihar, V. 1992. Clinical evaluation of workers handling melamine formaldehyde resin. Clin. Toxicol. 30:677-681.
109. Sugita, T., Ishiwata, H., Yoshihira, K., and Maekawa, A. 1994. Determination of melamine and three hydrolytic products by liquid chromatography. Bull. Environ. Contam. Toxicol. 44:567-571. (Pubitemid 20279154)
110. Teelman, K., and Niemann, W. 1979. The short term fate of dischargeable glass beads implanted surgically in the mouse urinary bladder. Arch. Toxicol. 42:51-61. (Pubitemid 9248332)
111. Tennant R. W., Stasiewica, S., and Spalding, J. W. 1986. Comparison of multiple parameters of rodent carcinogenicity and in vitro genetic toxicity. Environ.Mutagen. 8:205-227.
112. Thompson, M. E., Lewin-Smith, M. R., Kalasinsky, V. F., Pizzolato, K. M., Fleetwood, M. L., McElhaney, M. R. and Johnson, T. O. 2008. Characterization of melamine-containing and calcium oxalate crystals in three dogs with suspected pet food-induced nephrotoxicosis. Vet. Pathol. 45:417-7426.
113. Tritscher, A. 2009. Personal communication to WHO dated April 6, 2009 regarding the organs of crystal deposition in Chinese infants that consumed melamine-contaminated milk. World Health Organization Joint Secretary to JECFA and JMPR, Department of Food Safety, Zoonoses and Foodborne Diseases. Geneva: World
114. Health Organization. U.S. Environmental Protection Agency. 1984. Cyromazine; Proposed tolerance. Fed. Reg. 49(83):18120-18125.
115. U.S. Environmental Protection Agency. 1988. Melamine, toxic chemical reference reporting; community right-to-know. Fed. Reg. 53(116):23128-23131.
116. U.S. Environmental Protection Agency. 1991. National primary drinking water regulations: Final rule. Fed. Reg. 56(20):3526-3614.
117. U.S. Environmental Protection Agency. 2000. Benchmark dose technical guidance document- External review draft. EPA/630/R-00/ 001. Risk assessment forum. Available at: www.epa.gov/ncea/bmds.htm
118. U.S. Environmental Protection Agency. 2005. Guidelines for carcinogen risk assessment. EPA/ 630/P-03/001B. March 2005. Available at: http://cfpub.epa.gov/ncea/raf/recordisplay. cfm?deid=116283.
119. U.S. Environmental Protection Agency. 2007. 1990 HPV company/chemical list. Office of Pollution Prevention and Toxics. ChemRTK HPV Challenge Program. Available at: http:// www.epa.gov/HPV/pubs/general/hpvcolst. htm. Updated November 27, 2007.
120. U.S. Environmental Protection Agency. 2008. Benchmark Dose Software, Version 2.0. National Center for Environmental Assessment, Office of Research and Development. Available at: http://www.epa.gov/ncea/
121. bmds.htm. U.S. Environmental Protection Agency. 2009. Health effects testing guidelines. U.S. Code of Federal Regulations, Title 40, Part 798. Washington, DC: U.S. Environmental Protection
122. Agency. U.S. Food and Drug Administration. 2007. CEDI/ADI table. Center for Food Safety and Applied Nutrition. September. Available at: http://www.cfsan.fda.gov/?dms/opa-tedi.html. Accessed December 11, 2007.
123. U.S. Food and Drug Administration. 2008a. Interim melamine and analogues safety/risk assessment. Center for Food Safety and Applied Nutrition. May 25, 2007. Accessed January 18, 2008. Available at: http:// www.cfsan.fda.gov/?dms/ melamra.html
124. U.S. Food and Drug Administration. 2008b. Interim safety and risk assessment of melamine and its analogues in food for humans. Center for Food Safety and Applied Nutrition. October 3, 2008. Accessed December 3, 2008. Available at: http:// www.cfsan.fda.gov/?dms/melamra3.html.
125. U.S. Food and Emergency Response Network. 2007. LC/MS/MS screen for the presence of melamine in swine and poultry tissues. SOP No: FERN-CHE.0003.00. May 2007. Available at: http://www.fsis.usda.gov/PDF/FERN- CHE-0003.pdf. Accessed November 19, 2008.
126. Weast, R. C., ed., 1984. CRC handbook of chemistry and physics, 65th ed. p C-368. Boca Raton FL: CRC Press.
127. Wang, I. J., Chen, P. C., and Hwang, K. C. 2009. Melamine and nephrolithiasis in children in Taiwan. N. Engl. J. Med. 360: 1157-1158.
128. Whitesides, G. M., Mathias, J. P., and Seto, C. T. 1991. Molecular self-assembly and nanochemistry: A chemical strategy for the synthesis of nanostructures. Science 254: 1312-1319.
129. World Health Organization. 2008a. Melamine and cyanuric acid: Toxicity, preliminary risk assessment and guidance on levels in food. September 25. Available at: http://www. who.int/foodsafety/fs-management/Melamine. pdf. Accessed November 17, 2008.
130. World Health Organization. 2008b. Expert meeting to review toxicological aspects of melamine and cyanuric acid. December. Available at: http://www.who.int/foodsafety/ fs-management/Exec-Summary-melamine.pdf and http://www.who.int/foodsafety/fs- management/conclusions-recommendations. pdf. Accessed February 6, 2009
131. World Health Organization/International Programme on Chemical Safety. 2005. Harmonization project document no. 2. Chemical-specific adjustment factors for interspecies differences and human variability: Guidance document for use of data in dose/concentration-response assessment. World Health Organization/International Programme on Chemical Safety, Geneva. Available at: http://whqlibdoc.who.int/publications/2005/9241546786-eng.pdf.
132. Worzalla, J., Kaiman, B., Johnson, B., Ramirez, G., and Bryan G. 1974. Metabolism of hexamethylmelamine-ring-14C in rats and man. Cancer Res. 34:2669-2674.
133. Wu, Y. N., Zhao, Y. F., and Li, J. G. 2009. A survey on occurrence of melamine and its analogues in tainted infant formula in China. Biomed. Environ. Sci. 22:95-99.
134. Xin, H., and Stone, R. 2008. Tainted milk scandal. Chinese probe unmasks high-tech adulteration with melamine. Science 322: 1310-1311. (Pubitemid 352775217)
135. Yhee, J.-Y., Brown, C. A., Yu, C.-H., Kim, J.-H., Poppenga, R., and Sur, J.-H. 2009. Retrospective study of melamine/cyanuric acid-induced renal failure in dogs in Korea between 2003 and 2004. Vet. Pathol. 46:348-354.
136. Zhang, L., Wu, L. L., Wang, Y. P., Liu, A. M., Zou, C. C., and Zhao, Z. Y. 2009. Melamine-contaminated milk products induced urinary tract calculi in children. World J. Pediatr. 5:31-35.
137. Zhu, S. L., Li, J. H., Chen, L., Bao, Z. X., Zhang, L. J., Li, J. P., Chen, J. H., and Ji, K. M. 2009. Conservative management of pediatric nephrolithiasis caused by melamine-contaminated milk powder. Pediatrics 123:e1099-e1102.